(Companies Covered: Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Merck & Co., F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis International AG, AbbVie, Inc., Pfizer Inc, Sanofi S.A., Incyte, EMD Serono, Inc., Gilead Sciences Inc., Prometheus Therapeutics & Diagnostics, Aduro BioTech, Galena Biopharma, Bavarian Nordic,)
The global immuno-oncology drugs market is expected to decline from $59.64 billion in 2019 to $57.34 billion in 2020 at a compound annual growth rate of -3.86%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $80.11 billion in 2023 at a compound annual growth rate of 11.79%.
Read More On The Global Immuno-Oncology Drugs Market Report At –
https://www.thebusinessresearchcompany.com/report/immuno-oncology-drugs-global-market-report-2020-30-covid-19-growth-and-change
The immuno-oncology drugs market consists of sales of immuno-oncology drugs used for the treatment of cancer and related services by entities (organizations, sole traders and partnerships) that produce immuno-oncology drugs for cancer treatment. Immuno-oncology is the artificial stimulation of the immune system to treat cancer, improving the immune system`s ability to fight the disease. The market consists of revenue generated by the companies manufacturing immuno-oncology drugs by the sales of these products.
Global Immuno-Oncology Drugs Market Segmentation –
1) By Type: Monoclonal Antibodies, Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines, Others.
2) By Therapeutic Application: Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Prostate Cancer, Bladder Cancer, Others.
3) By End-user: Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes.
Global Immuno-Oncology Drugs Market Driver –
The rise in the number of cancer cases across the globe is likely to contribute to the growth of the immune-oncology drugs market. The four most common types of cancers worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of the new cancer cases. The immunotherapy drugs cost more than the other cancer drugs and people who need immunotherapy for cancer, too often are not able to afford it. High costs associated with drugs is a major issue faced by patients across the globe. The pressure to contain costs and demonstrate value is widespread.
Request For A Sample Of The Global Immuno-Oncology Drugs Market Report At –
https://www.thebusinessresearchcompany.com/sample.aspx?id=3455&type=smp
Few Points From The Global Immuno-Oncology Drugs Market TOC
1. Executive Summary
2. Immuno-Oncology Drugs Market Characteristics
3. Immuno-Oncology Drugs Market Size And Growth
3.1. Global Immuno-Oncology Drugs Historic Market, 2015 – 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Immuno-Oncology Drugs Forecast Market, 2019 – 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Immuno-Oncology Drugs Market Segmentation
4.1. Global Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015
2019, 2023F, 2025F, 2030F, $ Billion
4.2. Global Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
4.3. Global Immuno-Oncology Drugs Market, Segmentation By End-user, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5. Immuno-Oncology Drugs Market Regional And Country Analysis
5.1. Global Immuno-Oncology Drugs Market, Split By Region, Historic and Forecast, 2015-2019,
2023F, 2025F, 2030F, $ Billion
5.2. Global Immuno-Oncology Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
Media Contact
Company Name: The Business Research Company
Contact Person: Oliver Guirdham
Email: Send Email
Phone: +44 20 7193 0708
Address:
City: London
State: Greater London
Country: United Kingdom
Website: https://www.thebusinessresearchcompany.com/